Research to Prevent Blindness

Stem Cells Regenerate Human Lens After Cataract Surgery In Children

In a breakthrough that could have broader implications for human tissue and organ regeneration, RPB-supported scientists report that, by leaving local stem cells intact during surgery to remove the lens in infants who develop congenital cataracts, a functional lens can be regrown.

The researchers are now looking to expand their work to treating age-related cataracts. The potential resulting paradigm shift in cataract surgery would be especially timely, since the world's aging population has been predicted to double the need for cataract surgeries over the next 20 years.

Read the story.

Read the study.

Related News: Cataract, Pediatric , Stem Cell Therapy, Top Story

Researchers Build An “Aging Clock” To Help Treat Eye Disease

The new way to measure ocular aging opens treatment avenues for numerous eye diseases.

Research to Prevent Blindness and the American Academy of Ophthalmology Award Big Data Research Grants for Improved Patient Care

The American Academy of Ophthalmology (AAO) and Research to Prevent Blindness (RPB) today announced the 2023 recipients of the RPB/AAO Award for IRIS Registry Research.

In Memoriam: Herbert J. Siegel

RPB acknowledges the passing of a dedicated former Board member.

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2024 Recipient of RPB David F. Weeks Award for Outstanding Vision Research

Patricia Ann D’Amore, PhD, MBA, is recognized for ground-breaking contributions to the field of vision research.

RPB-Supported Researcher Makes Progress on Diabetic Retinopathy Treatment

Dr. Akrit Sodhi at Johns Hopkins Medicine has published a new study showing promise for an experimental treatment to prevent or slow vision loss in people with diabetes.